药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Marimastat
Isavuconazole
The serum concentration of Bupropion can be decreased when it is combined with Isavuconazole.
Marimastat
Alpelisib
The serum concentration of Bupropion can be decreased when it is combined with Alpelisib.
Marimastat
Solriamfetol
The risk or severity of adverse effects can be increased when Solriamfetol is combined with Bupropion.
Marimastat
Esketamine
The risk or severity of adverse effects can be increased when Bupropion is combined with Esketamine.
Marimastat
Tocilizumab
The metabolism of Bupropion can be increased when combined with Tocilizumab.
Marimastat
Emapalumab
The metabolism of Bupropion can be increased when combined with Emapalumab.
Marimastat
Siltuximab
The metabolism of Bupropion can be increased when combined with Siltuximab.
Marimastat
Secukinumab
The metabolism of Bupropion can be increased when combined with Secukinumab.
Marimastat
Certolizumab pegol
The metabolism of Bupropion can be increased when combined with Certolizumab pegol.
Marimastat
Golimumab
The metabolism of Bupropion can be increased when combined with Golimumab.
Marimastat
Rilonacept
The metabolism of Bupropion can be increased when combined with Rilonacept.
Marimastat
Canakinumab
The metabolism of Bupropion can be increased when combined with Canakinumab.
Marimastat
Apremilast
The metabolism of Bupropion can be increased when combined with Apremilast.
Marimastat
Afelimomab
The metabolism of Bupropion can be increased when combined with Afelimomab.
Marimastat
Abatacept
The metabolism of Bupropion can be increased when combined with Abatacept.
Marimastat
Amifampridine
The risk or severity of seizure can be increased when Bupropion is combined with Amifampridine.
Marimastat
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Bupropion.
Marimastat
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Bupropion.
Marimastat
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Bupropion.
Marimastat
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Bupropion.